composed of a 43 kD chain and a 38 kD chain on the leukemic cells. In addition to reacting with the leukemic T cells, this antibody was shown to react with 1-2% of circulating T cells in all individuals tested. The current study was initiated to investigate the nature of these reactive cells and to test the hypothesis that binding of mAb $511 to these cells would result in the activation of resting T lymphocytes. The data demonstrate that the population of normal T lymphocytes reactive with $511 is composed of resting cells and that both soluble and Sepharose-bound antibody induce proliferation of these cells. Additionally, the $511 molecules on the normal $511-bearing T lymphocytes appear to be similar to those on the original leukemic cells. A preliminary report of these findings has been presented (14) .
Materials and Methods
Monoclonal Antibodies. Preparation and characterization of the murine mAb $511 has been previously described (4) . The $511 mAb, an IgG2bK antibody, was purified from ascites by fractionation with 50% ammonium sulfate and elution from DEAE cellulose (DE-52; Whatman, Inc., Clifton, NJ) using a 0-0.2 M NaCl gradient. This antibody preparation was coupled to cyanogen bromide-activated Sepharose 4B beads (Pharmacia Fine Chemicals, Piscataway, NJ) at a ratio of 6 mg protein bound to 0.5 g beads using standard conditions. A control mAb reacting with the hapten dinitrophenyl (DNP) (provided by Dr. D. H. Katz, Medical Biology Institute, La Jolla, CA) was prepared in the same manner as $511. Antibodies OKT-3, OKT-4, and OKT-8 were obtained commercially (Ortho Diagnostic Systems, Inc., Raritan, NJ) and mAb 9.6 was the gift of Dr. John Hansen, Fred Hutchinson Cancer Research Center, Seattle, WA.
Stimulation of Normal T Cells. Peripheral blood mononuclear cells were obtained and separated by rosetting with neuraminidase-treated sheep erythrocytes. Autologous nonrosetting cells were irradiated at 3,000 rad and mixed with rosetting cells at a I:I0 ratio when indicated. These cells were cultured in RPMI 1640 medium supplemented with 20% human AB serum and serial dilutions of purified mAb, phytohemagglutinin (PHA) (Gibco Laboratories, Grand Island, NY), or 10% lectin-free IL-2 (Electro-Nucleonics Inc., Fairfield, N J). Cells were cultured for 9 d in flat-bottom microtiter plates (Linbro; Flow Laboratories, Inc., McLean, VA) and then analyzed for [3H]thymidine incorporation on alternate days. Proliferation was calculated from the mean thymidine incorporation of quadruplicate samples of cells cultured in the presence of mAb compared with cells cultured in media alone. Data are expressed as a proliferation index: (antibody culture mean cpm)/(media culture mean cpm).
Simultaneous Surface Immunofluorescence and DNA Cell Cycle Analysis. T cells were obtained by sheep erythrocyte rosetting and were stained by indirect immunofluorescence with mAb and fluorescein isothiocyanate-conjugated (FITC) goat anti-mouse immunoglobulin (Tago, Inc., Burlingame, CA) in saturating conditions. For DNA cell cycle analysis, these cells were fixed overnight in 70% ethanol, washed, and suspended at 5 × 105/ml in phosphate-buffered saline containing 18 #g/ml propidium iodide and 40 •g/ml RNase (Sigma Chemical Co., St. Louis, MO) (15) . After 30 min the cells were analyzed for simultaneous surface FITC fluorescence and DNA fluorescence using a 50-H Cytofluorograf (Ortho Diagnostic Systems).
Generation of $51 I-reactive T Cell Lines. Five million peripheral blood T cells were suspended in 0.5 ml of RPMI 1640 medium with 10% fetal calf serum, to which an equal volume of 2% $511-Sepharose 4B beads was added. The suspension was centrifuged and then incubated at 4°C for 30 min. The pellet was gently resuspended and the $511-Sepharose was allowed to settle in a conical tube for 15 min. After settling, the $511-Sepharose and any bound cells were removed from the bottom of the tube and placed in medium containing 10% IL-2. Proliferating cells were expanded in this medium with addition of new $511-Sepharose every 7-10 d. The surface molecules on a cell line obtained using this method and on the original leukemic cells were ~sI-labeled using lactoperoxidase, immunoprecipitated with mAb $511, and analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) as previously described (4, 5) .
Results

Induction of T Cell
Proliferation by Soluble $511. Our previous study (4) demonstrated that 1-2% of circulating peripheral blood T cells from all individuals tested were $511 +. If the $511 molecule represents the antigen receptor on these normal T lymphocytes, then $511 antibody binding may specifically induce activation and proliferation of these normal cells in a manner similar to specific antigen-induced activation. This hypothesis was evaluated by obtaining peripheral blood T cells from three individuals with 1.5-2.6% circulating $511-reactive T cells. These cells were cultured for 9 d in the presence of soluble mAb, either $511 or anti-DNP, and irradiated nonrosetting cells. Cultures from all three individuals demonstrated T cell proliferation when cultured with $511 and no proliferation when cultured with anti-DNP. The results of the proliferation induced on sequential days by mAb $511 and anti-DNP at 1.6 #g/ml are displayed in Fig. 1 . They demonstrate that, over 9 d, the proliferation index for anti-DNP was between 0.6 and 2.0 for all three individuals, while the $511 mAb consistently induced proliferation starting on day 3 with an index of 3.0-17.2. The stimulation on day 3 continued and reached a maximum on day 7, with the proliferation index ranging between 41.6 and 185.1. After this peak of activation on day 7, the amount of thymidine incorporated on day 9 decreased, presumably due to extensive cell proliferation and limitations of the culture conditions. Additional experiments were also performed using the previously described mAb S 160 (4) as the control antibody. This mAb detects a private idiotope of the antigen receptor molecule on the same leukemic cells used to generate mAb $511. As with anti-DNP, mAb S 160 also failed to activate normal T cells (data not shown).
The dependence of this stimulation on antibody concentration and the pres- DAY. ence of autologous nonrosetting cells was evaluated. Initial experiments used the same culture conditions as above, which contained 10% irradiated nonrosetting cells. Table I demonstrates that, over a range of antibody concentration from 0.01 to 10 #g/ml, proliferation was not induced by anti-DNP. However, over this same range mAb $511 induced about a threefold increase in proliferation on day 3 and a concentration-dependent maximum proliferation on day 7 of 49-61 times greater than background. This same concentration range was examined for stimulation of T cells without the addition of non-T cells as accessory cells. As before, no stimulation occurred with anti-DNP. The $511 cultures, however, showed a twofold increase on day 3 and a pronounced concentration-dependent proliferation on day 7. The proliferation on day 7 in these T cell cultures was comparable to that observed in cultures to which irradiated nonrosetting cells were added. The extensive proliferation induced by mAb $511 is striking when one compares the proliferation index of $511 cultures (127 on day 7), which activates 2% of the T cells in culture, and the proliferation index of PHA (214 on day 3), which activates the majority of T cells in culture.
The thymidine incorporation observed in the $511 cultures could represent either specific proliferation of the $511-bearing cells or nonspecific expansion of recruited cells. The latter was especially possible since some proliferation occurred in the IL-2 cultures without the addition of antibody (Table I) . Thus, the nature of the proliferating cells in IL-2 containing cultures and antibodycontaining cultures was examined. T cells were cultured in the presence of either $511, anti-DNP, IL-2, or PHA and additional irradiated non-T cells, washed twice in media on day 7, and then cultured for two additional days in media containing 10% IL-2. The results of immunofluorescence staining at this time showed that, in $51 l-stimulated cultures, 34% of the cells were $511 + ( Fig. 2A ), 88% were OKT-3 ÷, and 40% were Ia +. This expansion of the $511 population compares with 0.9% $511 + cells in the anti-DNP cultures ( Fig. 2B ) and 1.9% in the media control cultures. Fluorescence staining of cells activated by PHA for either 3 or 7 d also showed only 2.2 or 1.2% $511-bearing cells, respectively. Those cells activated by the IL-2 preparation were also analyzed for $511 expression. As shown in Fig. 2C , only 0.6% of these proliferating cells were $511 +. Thus, the proliferating cell in the $511-stimulated culture is primarily the $511-bearing lymphocyte rather than nonspecifically recruited cells, and the proliferation observed in the IL-2-containing cultures (Table I) is not due to selective expansion of $511-reactive cells.
Cell Cycle Analysis of Circulating S511-bearing T Lymphocytes.
The preceding experiments indicate that mAb $511 could specifically activate the circulating $511-reactive cell in normal individuals. Previous studies (2, 3, 5, 6) in which cells were stimulated with mAb detecting the T cell antigen receptor have used cells that were previously activated. To investigate whether the $511-bearing cell was resting or was previously activated and therefore analogous to these cell lines, T lymphocytes reacting with mAb $511 were studied by cell cycle analysis.
T lymphocytes were stained by indirect immunofluorescence with either the second antibody, FITC-conjugated goat anti-mouse immunoglobulin (GAMG), alone or with mAb 9.6, which detects the sheep erythrocyte receptor, or mAb $511. After surface staining and fixation, the cells were analyzed for DNA content measured by propidium iodide fluorescence. To discriminate between single cells in the S+G~/M phase of the cell cycle and clumps of cells artifactually induced by the fixation procedure, the initial gating for flow cytometry compared pulse width vs. pulse area of the red DNA fluorescence signal. For a clump of cells, such as a doublet with a diploid chromosome number in each cell, the total DNA fluorescence will be the same as a single dividing cell with a tetraploid chromosome number; however, the time of flight across the laser beam, as measured by pulse width, frequently will be longer for the doublet than the single cell, while the total area under the signal peak could be similar. Thus, to discriminate between single cells with S+G~/M DNA content and the artifactual clumps with doubled or higher multiple DNA content, these gating parameters were useful. The gate that was used extended along the pulse area axis to include at least the region where single cell GJM fluorescence would occur. For this reason, a few of these clumped doublets were necessarily included in the gate, while most of the clumps with a pulse width greater than that detected for the majority of single cells were excluded. This artifact can be seen in the last column of Table II and will be discussed below.
The analysis of the peripheral blood T cells of one individual studied in this manner is displayed in Fig. 3 erythrocyte receptor and were present exclusively in the G0/G1 state (region 2), confirming the data obtained with the FITC-GAMG control. When T cells were stained with mAb $51 1 (Fig. 3C), 1 .5% of the cells were surface fluorescence positive and all were G0/G1 (region 2). No $511 fluorescent cells were detected in the region of activated cells (region 4). To confirm the ability of this technique to detect cycling cells, an IL-2-dependent cell line enriched for $511 antigen expression, which had been derived from the same donor as the normal T cells, was analyzed in an identical manner (Fig. 3D) . This cell line demonstrated that $511 ÷ cells can be detected in the S+Gz/M phase of the cell cycle as well as in the G0/Gl phase.
All three individuals used for the initial stimulation studies (Fig. 1) were analyzed using this technique to ensure that no difference existed in the cell cycle of the various $511 populations. These data are presented in Table II and confirm the results described above. All samples failed to demonstrate any cells in the FITC-nonfluorescent cycling cell compartment. As before, the FITC-GAMG control and the mAb 9.6 demonstrated that FITC-fluorescent and -nonfluorescent cells were present only in G0/G~. The mAb $511 stained 1.5-2.6% of the circulating T lymphocytes, all of which were in G0/GI. This percentage of $511-reactive cells correlated very well with our previous report of the amount of circulating $511-reactive cells. For all three individuals and all three surface stains, a population of 0.9-1.4% was consistently detected in the surface FITC fluorescence-positive cycling cell compartment. This percentage is related to the small number of doublets included in the initial gate described above and thus represents nonspecific background counts. This interpretation is TABLE § mAb 9.6 recognizes the sheep erythrocyte receptor.
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supported by the finding that this value does not change for any of the surface stains and, specifically, does not increase with the $511 stain, as would be the case if any $511 ÷ cells were activated. Thus, the $511-reactive T cells exist in the G0/G~ phase. These cell cycle studies of the circulating $511-bearing cells, plus the lack of preferential expansion of $511-bearing cells when activated by PHA or IL-2 described in the immunofluorescence studies above, indicate that the $511-reactive T lymphocyte does not demonstrate evidence of prior activation.
Isolation and Expansion of S51I-reactive T Lymphocytes.
The $511-bearing T cell population from normal individuals was isolated by binding to $511-Sepharose. Five normais were studied and, in each case, the $511-bearing T cells proliferated after $511-Sepharose exposure. These S511-reactive cells were expanded in IL-2-containing media and analyzed between days 14 and 21 by immunofluorescence. In each case at least 60% $511 ÷ cells could be demonstrated. When these lines were examined for expression of OKT-4 and OKT-8, both surface markers were detected (data not shown), suggesting that these early cell lines are polyclonal with respect to surface phenotype and that the $511 marker is not restricted to a specific T celt subset. One line was passaged for >2 months in IL-2-containing medium with periodic addition of $511-Sepharose. An aliquot of cells removed from this culture at that time was freed of $511-Sepharose and grown in IL-2 medium for 24 h to avoid modulation of the antigen. When these cells were stained with the $511 mAb and analyzed by flow cytometry, >90% of the cells in culture were $511 + (Fig. 2D) . This enrichment and expansion of the reactive cells permitted the analysis of the surface molecules bearing the $511 epitope.
Initial Characterization of the $511 Antigen Present on a Polyclonal T Cell Line. This cell fine was analyzed before cloning to investigate two questions regarding the structure of the normal $511 molecule. First, since the molecule expressed on the original leukemic T cells differed slightly from most other molecules described, did normal cells express a similar molecule or did the malignant clone synthesize a defective molecule? Second, did the $511 molecule on these normal cells exhibit molecular heterogeneity in this uncioned population? The molecule present on the $511-bearing leukemic T cells was compared with the molecules present on the normal cell line, using immunoprecipitation and SDS-PAGE analysis (Fig. 4) . The mobility of the unreduced molecule on the leukemic cells was 77 kD (compared with human transferrin as a molecular weight marker) which is compatable with our previous reports. After reduction this molecule was shown to be a heterodimer composed of two chains, with mobilities of 43 and 38 kD. In contrast to the single molecule on the leukemic cells, the unreduced molecules immunoprecipitated by $511 from the cell line migrated as a diffuse band between 77 and 90 kD. When these molecules were reduced, the heterodimeric structure was present; however, the mobility of the two chains was not identical to that of the chains present on the leukemic cell. The heavier chain showed a greater heterogeneity of mobility, migrating between 43 and 55 kD, while the lighter chain migrated between 38 and 40 kD. Thus, by immunoprecipitation and SDS-PAGE analysis, it appears that normal $51 l- FIGURE 4 . SDS-PAGE analysis after immunoprecipitation using mAb $511 of ~SI-labeled surface molecules from the original leukemic cells (lanes 1 and 3) or a polyclonal IL-2-dependent, $51 l-bearing T cell fine from a normal individual (2 and 4). Samples were electrophoresed using nonreducing (1 and 2) or reducing (3 and 4) conditions. A band migrating at 105 kD in 2 and 4 was not influenced by reduction and its significance is unclear. The position of the molecular weight markers is indicated. These were human transferrin (79 kD), bovine albumin (69 kD), ovalbumin (43 kD), and trypsinogen (24 kD).
bearing T cells possess a surface receptor molecule comparable in structure to that on the leukemic cells, but with greater molecular variability.
Discussion
The present study used mAb $511 previously shown (4) to crossreact with a determinant of the T cell antigen receptor expressed on ~2% of circulating T cells from all individuals tested to date. Since this epitope is present on cells from all normal individuals, the mAb does not appear to bind to an allotypic marker like that described for the murine T cell antigen receptor (13) . Our experiments attempted to answer several questions about the normal $511-bearing T lymphocytes. First, could these cells be specifically stimulated by the antibody and did they show evidence of activation before antibody exposure? Second, how did the T cell antigen receptor of the normal $511 + T cells compare with that of the leukemic T cells?
The ability of mAb $511 to activate normal $511-reactive T cells in a manner analogous to antigen stimulation was investigated using soluble $511 antibody. Proliferation was induced in a time-and concentration-dependent manner by culturing normal T cells ifi the presence of $511 mAb and irradiated non-T cells as accessory cells. In contrast, an anti-DNP mAb and a previously described mAb (S160) that reacts with a private idiotope on the $511-bearing leukemic cells (4), failed to induce proliferation under these same conditions. Several observations suggested that mAb S511 was acting directly on $511 + T cells to cause their proliferation. The small proliferation index on day 3, when compared with that of PHA, implies that only a few cells were proliferating at this point. Extensive proliferation of $511 + cells was suggested when the peak proliferation index of $511 cultures (61 on day 7) was compared with the peak value obtained with PHA (222 on day 3) . Immunofluorescence analysis demonstrated that 34% of the cells in these $511 cultures were $511 + after 7 d. T cells nonspecifically activated by PHA or by IL-2 failed to demonstrate preferential expansion of these $511-bearing T lymphocytes. Thus, a selective expansion of the $511 population, rather than nonspecific cell recruitment, appears to be responsible for most of this brisk proliferative response.
Activation of normal T lymphocytes by the antigen receptor has not been previously reported using either mAb or antisera reacting with the antigen receptor (1) (2) (3) (4) (5) (6) (11) (12) (13) . Normal T lymphocytes, however, have been induced to proliferate by OKT-3 (16, 17) . Since the T3 molecule co-modulates with the antigen receptor molecule (2, 4, 5) and is closely associated with the 43 kD beta chain (18) , this nonclonally restricted, T3-induced activation probably uses the same mechanism as antigen receptor-induced proliferation. Thus, the major differences between the activation of normal T cells by OKT-3 and $511 are the number of cells activated and the molecule within the antigen receptor complex that is bound by the mAb. The different kinetics of $511 activation compared with OKT-3 activation probably reflect the small number of cells activated, similar to the proliferation of small populations in antigen-specific systems (19) (20) (21) or mixed lymphocyte reactions (22, 23) .
Our initial studies of $511-induced activation used T cells and a small percentage of irradiated nonrosetting cells to function as accessory cells. The requirement for these additional cells was investigated by culturing T cell preparations alone with antibody. Results indicated that there were no major differences in the extent of proliferation generated with or without added accessory cells. T cells alone were also used in developing $511-reactive lines by $511-Sepharose activation. Previous studies (5) in this laboratory have demonstrated that leukemic T cells containing <1% monocytes can be induced to proliferate by an anti-T cell receptor mAb. Studies using T cell lines and hybridomas also may not require the addition of accessory cells to induce clonal proliferation by clonotypic mAb (2, 6, 24) . Similarly, an alternate pathway of T cell activation using mAb reacting with the T11 molecule may not require the presence of monocytes (25) . Since the rosetted T cells used in our experiments probably contain a few monocytes, and since the $511 mAb is IgG2b and would be expected to bind fairly well to Fc receptors of accessory cells, the absolute requirement for these cells cannot be determined from our studies. However, the above-mentioned observations together suggest that accessory cell populations may not be essential for antibody-induced activation.
Several laboratories, including our own, have shown (2, 3, 5, 6, 13) that, when T cell lines, hybridomas, or leukemias were cultured in the presence of either soluble or Sepharose-bound anti-T cell receptor mAb, a specific proliferative response could be generated. In each of these systems, the target T cells were previously activated. The $511-bearing normal cells were studied to determine if these cells were similarly activated. By cell cycle analysis at least 98% of circulating T cells were present in the G0/G~ phase, and all $511-reactive cells were in G0/G1. These findings, based on DNA analysis of individual $511-bearing cells, are in agreement with studies by Darzynkiewicz et al. (26, 27) and previous work (reviewed in 28) that simultaneously analyzed DNA and RNA content of cells and demonstrated that circulating lymphocytes are normally in the Go or Glq phase (27) . Since the Tac antigen has been shown (29) to be expressed 8-16 h after activation even without an increase in cellular DNA content, cells were cultured in IL-2-containing media as a different method of detecting activation. Immunofluorescence analysis demonstrated that no preferential increase in the $511-reactive cells occurred. These two results suggest that the S511-reactive cells are not activated in vivo. The possibility of a nonquantifiable degree of preactivation, however, cannot be totally excluded, since the assays used sheep erythrocyte-rosetted T cells and, as mentioned above, the erythrocyte receptor has been implicated as an alternate pathway of T cell activation (25) . Thus, the present study extended our prior observations on the presence of a small S511-reactive population in the circulation of normals, demonstrating the lack of prior quantifiable activation of these cells.
The ability to stimulate normal $511-reactive T lymphocytes was used to develop IL-2-dependent cell lines expressing the $511 epitope. The leukemic $511 molecule has been shown to differ from most other antigen receptor molecules in the mobility of the two chains (43 and 38 kD) and the isoelectric points (pI) of each chain (near neutral pI) (1-6). SDS-PAGE analysis of the $511-bearing normal T cell line demonstrated that the relative mobility of the $511 molecule that was derived from normal cells was comparable to that of the molecules on the leukemic cells. Thus, a subset of normal T lymphocytes routinely synthesizes this form of antigen receptor molecule, implying that the disparity in mobility cannot be ascribed to a biosynthetic defect present in the malignant cells. One possible explanation for these differences is the presence of differences in glycosylation. That glycosylation accounts for a large portion of the molecular weight of the T cell antigen receptor has become evident from recent studies (7) (8) (9) (10) 30) . If this is the basis for the mobility differences in the $511 molecule, then $511 ÷ normal cells glycosylate either one or both polypeptide chains differently than most other antigen receptor molecules described. Since differential glycosylation can modulate the function of a common IgEbinding factor (31) and sugar moieties play a role in immune regulation by suppressor T cells (32, 33) , differences in glycosylation of the antigen receptor may have a functional significance. Another explanation for the differences in mobility is the synthesis of a polypeptide different than those previously described. Although current evidence does not suggest the existence of T cell receptor isotypes, recent studies indicate that this possibility cannot be completely excluded (34, 35) . Both of these possible explanations are under study. Summary A previous study from this laboratory described a monoclonal antibody, $511, that reacted with the T cell antigen receptor on a human T cell leukemia and also on 1-2% of circulating T lymphocytes in all normal individuals tested. The data presented in the present study demonstrate that, when normal T lympho-cytes are cultured with or without irradiated non-T cells in the presence of soluble $511 antibody, a concentration-and time-dependent proliferation of the $511-reactive population occurred. Proliferation indices as high as 184 times greater than control were observed, which represents a major stimulatory effect on the initially minor $511 + subset. When $511 + ceils were studied for evidence of prior activation, they were shown to be unresponsive to interleukin 2 (IL-2) unless exposed to $511 antibody, and were shown to be in the G0/Gl phase of the cell cycle. Thus, the $511 antibody activated resting normal T cells in a manner analogous to specific antigen binding to the T cell antigen receptor.
The leukemic $511 molecule has been shown previously to differ from most other antigen receptors in the mobility of the two chains at 43 and 38 kD and the neutral isoelectric point of each chain. Expansion of reactive normal cells by $511-Sepharose permitted the development of IL-2-dependent T cell lines enriched for $511-bearing cells. The antigen receptor molecules on one such polyclonai $511-enriched T cell line were immunoprecipitated with $511 antibody and shown to have comparable mobility to that present on the leukemic cells, but to possess a greater heterogeneity of mobility. Thus, the leukemic cells and normal cells express similar T cell receptor molecules. The differences in the $511 T cell antigen receptor molecule possibly relate to differences in glycosylation or polypeptide structure.
